标题
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
作者
关键词
-
出版物
Diabetes Therapy
Volume 11, Issue 1, Pages 37-52
出版商
Springer Science and Business Media LLC
发表日期
2019-12-08
DOI
10.1007/s13300-019-00728-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incretin-based therapies for patients with type 1 diabetes: a meta-analysis
- (2019) Lili Liu et al. Endocrine Connections
- Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
- (2019) Thomas Danne et al. DIABETES CARE
- International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors
- (2019) Thomas Danne et al. DIABETES CARE
- Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors
- (2019) Susan J. Bersoff-Matcha et al. ANNALS OF INTERNAL MEDICINE
- Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
- (2019) Chantal Mathieu et al. DIABETES CARE
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- SGLT inhibitors in type 1 diabetes: place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis ‐ the STOP DKA Protocol
- (2019) Ronald M Goldenberg et al. DIABETES OBESITY & METABOLISM
- Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes
- (2019) Iliana C. Lega et al. DIABETES OBESITY & METABOLISM
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- HbA1cand Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
- (2018) Thomas Danne et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
- (2018) Chantal Mathieu et al. DIABETES CARE
- Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials
- (2018) Haiyang Meng et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Type 1 diabetes
- (2018) Linda A DiMeglio et al. LANCET
- Synthetic Strategies toward SGLT2 Inhibitors
- (2018) Anderson R. Aguillón et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- (2018) Satish K. Garg et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012
- (2017) Elizabeth J. Mayer-Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fournier’s gangrene
- (2017) Y-K Wang et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
- (2017) John R Petrie et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
- (2017) Paresh Dandona et al. Lancet Diabetes & Endocrinology
- Type 1 diabetes mellitus
- (2017) Anastasia Katsarou et al. Nature Reviews Disease Primers
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis
- (2016) Heming Guo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
- (2016) Anne L. Peters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
- (2015) Volker Vallon Annual Review of Medicine
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
- (2015) Julio Rosenstock et al. DIABETES CARE
- Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study
- (2015) J. E. Schopman et al. DIABETES OBESITY & METABOLISM
- Glycemic Variability Is Associated With Quality of Life and Treatment Satisfaction in Patients With Type 1 Diabetes: Figure 1
- (2014) Shiho Ayano-Takahara et al. DIABETES CARE
- 7. Approaches to Glycemic Treatment
- (2014) DIABETES CARE
- Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study
- (2014) Yunjuan Zhao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
- (2014) Kurt J Griffin et al. Lancet Diabetes & Endocrinology
- Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
- (2013) D. M. Nathan et al. DIABETES
- Glycemic Variability: Both Sides of the Story
- (2013) A. Ceriello et al. DIABETES CARE
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study
- (2013) K.V.S. Hari Kumar et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial
- (2012) Satish Garg et al. Endocrine Practice
- Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
- (2012) Johan Farngren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
- (2012) Ele Ferrannini et al. Nature Reviews Endocrinology
- The physiology and pathophysiology of the neural control of the counterregulatory response
- (2011) Craig Beall et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
- (2011) Michael J. Jurczak et al. DIABETES
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
- (2011) S. L. Ellis et al. DIABETIC MEDICINE
- Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis
- (2011) M. W. Savage et al. DIABETIC MEDICINE
- Severe hypoglycemia in youth with T1DM: going, going … but not yet gone
- (2011) William V. Tamborlane PEDIATRIC DIABETES
- Epidemiology of Type 1 Diabetes
- (2010) David M. Maahs et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now